InMed Pharmaceuticals Inc (INM)

[gone3uo6]

Here is my call from earlier, we'll get some decent news in a couple weeks--right when PPS hits the 70's. I'm guessing it'll be an update on biosynthesis and/or announcement of ph1. We might see some intermediate news about a partnership. I've been watching weed stocks with a hawk eye and big boys are starting to merge, buy, and invest in the smaller growers/distributors and now biopharma. Emerald just dumped $400,000 into Nemus, Aurora / Cannimed / Newstrike takeover, Hiku (DOJA / TS Brandco), Aphria-led private placement with DOJA, Aphria’s acquisition of Broken Coast and so forth.

IMO, it's only a matter of time before expansion hungry companies come after Inmed. I know I would if I was in Aphria / Aurora / Canopy / Sunniva's position. Rec will probably rely heavily on dry flowers and extracts but the trend is toward extracts. Extracts will only get cheaper at production facilities increase capacity. Eventually we'll see a minimum where extractors will be turning to biosynthesis.

O it'll probably go a lot lower. No news, low volume, members cashing in and scaring off potential investors.

I think IMLFF is going to be quietly/steadily dropping down into the $0.70 range the next several weeks.